Login Pop-up

+ (351) 913908581
Thursday, May 23, 2024


Hitag Biotechnology is dedicated to developing recombinant proteins and immunogens without the need for adjuvants. By using a proprietary platform, “Fh8 r-PPure System”, Hitag Biotechnology produces soluble and highly pure recombinant proteins. This platform relies in the smallest solubilisation tag, 8 kDa, which has affinity to hydrophobic purification colums. A second proprietary platform, “H VerImmune Ligand”, conferes to a recombinant antigen the immunogenic features of a peptide. The immunisation procedure of this recombinant immunogen does not require coadministration of adjuvant.
Hitag Biotechnology is placed in Biocant Park, a Biotechnology Technological Park located in Portugal. 








Hitag Biotechnology, Lda
Parque Tecnológico de Cantanhede, N4 L4
3060 -197 Cantanhede, Portugal
E-mail: info@hitag.pt

Scroll to top